Topical betamethasone/fusidic acid in eczema: efficacy against and emergence of resistance in Staphylococcus aureus

By Menday AP   Noble WC  

Journal of Dermatological Treatment, Vol. 11, Iss. 3, 2000-09 ,pp. : 143-149

Informa Healthcare

Access to resources Recommend Favorite

Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor

By Köse O   Bülent Taştan H   Rıza Gür A   Kurumlu Z  

Journal of Dermatological Treatment, Vol. 13, Iss. 2, 2002-06 ,pp. : 77-79

Informa Healthcare

Access to resources Recommend Favorite

Fusidic acid suspension twice daily: a new treatment schedule for skin and soft tissue infection in children, with improved tolerability

By Török Eva   Somogyi Tihamér   Rutkai Krisztina   Iglesias Luis   Bielsa Isabel  

Journal of Dermatological Treatment, Vol. 15, Iss. 3, 2004-06 ,pp. : 158-163

Informa Healthcare

Access to resources Recommend Favorite

An Efficient New Formulation of Fusidic Acid and Betamethasone 17-Valerate (Fucicort^® Lipid Cream) for Treatment of Clinically Infected Atopic Dermatitis

By Larsen Finn Schultz   Simonsen Lene   Melgaard Anita   Wendicke Katja   Henriksen Anne S.  

Acta Dermato-Venereologica, Vol. 87, Iss. 1, 2007-01 ,pp. : 62-68

Medical Journals Limited

Access to resources Recommend Favorite

Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): Results of an open-label, paired-comparison, clinical trial

By Dall'Oglio F.   Nasca M. R.   Musumeci M. L.   Torre G. La   Ricciardi G.   Potenza C.   Micali G.  

Journal of Dermatological Treatment, Vol. 16, Iss. 1, 2005-02 ,pp. : 10-14

Informa Healthcare

Access to resources Recommend Favorite